Breaking News Instant updates and real-time market news.

ANFGF

Antofagasta

$24.00 /

+ (+0.00%)

15:02
04/12/21
04/12
15:02
04/12/21
15:02

Antofagasta price target raised to 1,150 GBp from 1,100 GBp at Deutsche Bank

Deutsche Bank analyst Liam Fitzpatrick raised the firm's price target on Antofagasta to 1,150 GBp from 1,100 GBp and keeps a Sell rating on the shares.

ANFGF Antofagasta
$24.00 /

+ (+0.00%)

04/12/21 Scotiabank
Antofagasta price target raised to 1,900 GBp from 1,600 GBp at Scotiabank
04/07/21 Barclays
Antofagasta price target raised to 1,150 GBp from 1,050 GBp at Barclays
03/24/21 Morgan Stanley
Antofagasta downgraded to Underweight from Equal Weight at Morgan Stanley
03/23/21 Morgan Stanley
Antofagasta downgraded to Underweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Hot Stocks
Apollo Global to commit up to $500M to Victory Park Capital » 08:18
06/14/21
06/14
08:18
06/14/21
08:18
APO

Apollo Global

$57.78 /

+0.45 (+0.78%)

Apollo Global Management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APO Apollo Global
$57.78 /

+0.45 (+0.78%)

APO Apollo Global
$57.78 /

+0.45 (+0.78%)

06:26 Today Citi
Athene Holding price target raised to $66 from $54 at Citi
05/14/21 Truist
Athene Holding price target raised to $68 from $56 at Truist
05/13/21 UBS
Athene Holding downgraded to Neutral from Buy at UBS
05/10/21 Citi
Citi boosts Apollo target to $72, opens 'Positive Catalyst Watch'
APO Apollo Global
$57.78 /

+0.45 (+0.78%)

APO Apollo Global
$57.78 /

+0.45 (+0.78%)

APO Apollo Global
$57.78 /

+0.45 (+0.78%)

APO Apollo Global
$57.78 /

+0.45 (+0.78%)

Hot Stocks
Aemetis signs $200M agreement for low carbon biofuels to be delivered in 2021-23 » 08:16
06/14/21
06/14
08:16
06/14/21
08:16
AMTX

Aemetis

$14.12 /

+0.3 (+2.17%)

Aemetis signed a biofuels…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMTX Aemetis
$14.12 /

+0.3 (+2.17%)

AMTX Aemetis
$14.12 /

+0.3 (+2.17%)

03/22/21 Credit Suisse
Aemetis initiated with an Outperform at Credit Suisse
03/19/21 Truist
Truist starts Aemetis at Buy on 'unique position for outsized growth'
03/19/21 Ascendiant
Aemetis price target raised to $30 from $4.25 at Ascendiant
03/18/21 Truist
Aemetis initiated with a Buy at Truist
Hot Stocks
Energy Focus in marketing partnership with FirstEnergy Home for LED lighting » 08:16
06/14/21
06/14
08:16
06/14/21
08:16
EFOI

Energy Focus

$5.13 /

+0.38 (+8.00%)

Energy Focus has entered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EFOI Energy Focus
$5.13 /

+0.38 (+8.00%)

EFOI Energy Focus
$5.13 /

+0.38 (+8.00%)

Recommendations
PLBY Group model updated following capital raise events, says Canaccord » 08:16
06/14/21
06/14
08:16
06/14/21
08:16
PLBY

PLBY Group

$43.54 /

+0.485 (+1.13%)

Canaccord analyst Austin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLBY PLBY Group
$43.54 /

+0.485 (+1.13%)

PLBY PLBY Group
$43.54 /

+0.485 (+1.13%)

05/13/21 Craig-Hallum
PLBY Group price target raised to $50 from $35 at Craig-Hallum
05/13/21 Canaccord
PLBY Group price target raised to $52 from $28 at Canaccord
04/07/21 Roth Capital
PLBY Group price target raised to $35 from $26 at Roth Capital
04/06/21 Canaccord
Canaccord sees Nifty Gateway partnership as initial step in PLBY's NFT strategy
PLBY PLBY Group
$43.54 /

+0.485 (+1.13%)

  • 10
    Jun
PLBY PLBY Group
$43.54 /

+0.485 (+1.13%)

PLBY PLBY Group
$43.54 /

+0.485 (+1.13%)

PLBY PLBY Group
$43.54 /

+0.485 (+1.13%)

Hot Stocks
BioCardia to be added to Russell Microcap Index » 08:16
06/14/21
06/14
08:16
06/14/21
08:16
BCDA

BioCardia

$4.35 /

-0.01 (-0.23%)

BioCardia announced it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCDA BioCardia
$4.35 /

-0.01 (-0.23%)

BCDA BioCardia
$4.35 /

-0.01 (-0.23%)

04/16/21 Dawson James
Dawson James downgrades BioCardia, sees capital raise this year
04/16/21 Dawson James
BioCardia downgraded to Neutral from Buy at Dawson James
09/21/20
Fly Intel: Top five analyst initiations
09/21/20 Alliance Global Partners
BioCardia initiated with a Buy at Alliance Global Partners
BCDA BioCardia
$4.35 /

-0.01 (-0.23%)

BCDA BioCardia
$4.35 /

-0.01 (-0.23%)

Hot Stocks
Bionano Genomics names Richard Shippy as chief business officer » 08:15
06/14/21
06/14
08:15
06/14/21
08:15
BNGO

Bionano Genomics

$7.57 /

-0.075 (-0.98%)

Bionano Genomics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

  • 20
    Jan
  • 08
    Jan
BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

Hot Stocks
Z Capital Partners confirms merger of Affinity Gaming, Sports Information Group » 08:15
06/14/21
06/14
08:15
06/14/21
08:15
GHAC

Gaming & Hospitality Acquisition

$9.79 /

+0.01 (+0.10%)

Z Capital Partners, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GHAC Gaming & Hospitality Acquisition
$9.79 /

+0.01 (+0.10%)

Hot Stocks
C4 Therapeutics first patient dosed in phase 1/2 clinical trial on CFT7455 » 08:14
06/14/21
06/14
08:14
06/14/21
08:14
CCCC

C4 Therapeutics

$42.15 /

+0.15 (+0.36%)

C4 Therapeutics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCCC C4 Therapeutics
$42.15 /

+0.15 (+0.36%)

CCCC C4 Therapeutics
$42.15 /

+0.15 (+0.36%)

06/04/21 H.C. Wainwright
C4 Therapeutics initiated with a Buy at H.C. Wainwright
03/31/21 BMO Capital
C4 Therapeutics initiated with an Outperform at BMO Capital
12/08/20 BMO Capital
C4 Therapeutics price target raised to $45 from $33 at BMO Capital
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
  • 02
    Oct
CCCC C4 Therapeutics
$42.15 /

+0.15 (+0.36%)

Hot Stocks
Moderna appoints Paul Burton as chief medical officer » 08:14
06/14/21
06/14
08:14
06/14/21
08:14
MRNA

Moderna

$218.69 /

+1.59 (+0.73%)

, JNJ

Johnson & Johnson

$164.99 /

-2.065 (-1.24%)

Moderna (MRNA) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

JNJ Johnson & Johnson
$164.99 /

-2.065 (-1.24%)

Hot Stocks
Teledyne FLIR wins Pentagon contract to develop chemical detectors » 08:13
06/14/21
06/14
08:13
06/14/21
08:13
TDY

Teledyne

$423.96 /

+2.215 (+0.53%)

Teledyne FLIR, part of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDY Teledyne
$423.96 /

+2.215 (+0.53%)

TDY Teledyne
$423.96 /

+2.215 (+0.53%)

06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
01/05/21 Canaccord
FLIR Systems downgraded to Hold from Buy at Canaccord
TDY Teledyne
$423.96 /

+2.215 (+0.53%)

TDY Teledyne
$423.96 /

+2.215 (+0.53%)

Recommendations
Nike price target lowered to $170 from $175 at UBS » 08:13
06/14/21
06/14
08:13
06/14/21
08:13
NKE

Nike

$131.93 /

+0.96 (+0.73%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

05/13/21
Fly Intel: Top five analyst initiations
05/13/21 BofA
Nike reinstated with a Neutral at BofA
05/11/21
Fly Intel: Top five analyst upgrades
05/11/21 Jefferies
Jefferies upgrades Nike to Buy with sportswear 'on fire' and showing no slowing
NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

NKE Nike
$131.93 /

+0.96 (+0.73%)

Hot Stocks
Mack-Cali Realty sells Red Bank office portfolio for $84M » 08:12
06/14/21
06/14
08:12
06/14/21
08:12
CLI

Mack-Cali Realty

$17.93 /

+0.045 (+0.25%)

Mack-Cali Realty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

04/19/21 Deutsche Bank
Mack-Cali Realty price target lowered to $13 from $14 at Deutsche Bank
12/10/20 Citi
Citi opens '90-day negative Catalyst Watch' on Mack-Cali Realty
08/04/20
Fly Intel: Top five analyst downgrades
08/04/20 Deutsche Bank
Mack-Cali Realty downgraded to Hold from Buy at Deutsche Bank
CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

CLI Mack-Cali Realty
$17.93 /

+0.045 (+0.25%)

Hot Stocks
Magenta Therapeutics appoints Thomas Beetham as chief legal officer » 08:12
06/14/21
06/14
08:12
06/14/21
08:12
MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, KNSA

Kiniksa

$14.85 /

+0.02 (+0.13%)

Magenta Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

03/18/21 Evercore ISI
Kiniksa sNDA looks to be approved by FDA, says Evercore ISI
11/24/20 Evercore ISI
Kiniksa initiated with an Outperform at Evercore ISI
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
07/17/20 JPMorgan
Kiniksa risk/reward attractive into Phase 2 data, says JPMorgan
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

  • 22
    Jul
  • 25
    Jun
KNSA Kiniksa
$14.85 /

+0.02 (+0.13%)

Hot Stocks
Lordstown Motors sinks 13% to $9.91 after CEO, CFO resign  08:11
06/14/21
06/14
08:11
06/14/21
08:11
RIDE

Lordstown Motors

$11.40 /

+0.795 (+7.50%)

 
ShowHide Related Items >><<
RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

06/10/21 Morgan Stanley
Morgan Stanley removes Lordstown rating, says market may be underestimating risk
06/08/21 RBC Capital
Lordstown Motors initiated with an Underperform at RBC Capital
05/28/21
Fly Intel: Top five analyst initiations
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

Recommendations
Tesla price target lowered to $812 from $974 at Canaccord » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
TSLA

Tesla

$609.92 /

-0.16 (-0.03%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

06/11/21 Credit Suisse
Tesla's Model S Plaid reinforces brand DNA, says Credit Suisse
06/11/21 Goldman Sachs
Goldman says Tesla's Model S Plaid helps illustrate technology leadership
06/08/21 GLJ Research
Tesla's China orders down 69% in Q2 versus Q1, says GLJ Research
06/08/21 Wedbush
Tesla China numbers rebound in 'big way,' says Wedbush
TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

TSLA Tesla
$609.92 /

-0.16 (-0.03%)

Hot Stocks
Iridium names Greg Pelton as new Chief Technical Officer » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
IRDM

Iridium

$39.05 /

-0.34 (-0.86%)

Iridium announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRDM Iridium
$39.05 /

-0.34 (-0.86%)

IRDM Iridium
$39.05 /

-0.34 (-0.86%)

04/05/21 William Blair
William Blair upgrades Gogo, sees shares going back to $13-$16
03/03/21
Fly Intel: Top five analyst upgrades
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
IRDM Iridium
$39.05 /

-0.34 (-0.86%)

Hot Stocks
Standard Lithium announces early conversion of loan facility with LANXESS » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
STLHF

Standard Lithium

$3.10 /

+0.035 (+1.14%)

Standard Lithium…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STLHF Standard Lithium
$3.10 /

+0.035 (+1.14%)

STLHF Standard Lithium
$3.10 /

+0.035 (+1.14%)

01/12/21 Canaccord
Standard Lithium initiated with a Speculative Buy at Canaccord
Initiation
Procore initiated with a Buy, $100 target at Canaccord » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
PCOR

Procore

$83.98 /

-2.47 (-2.86%)

Canaccord analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$83.98 /

-2.47 (-2.86%)

07:21 Today JPMorgan
Procore initiated with an Overweight at JPMorgan
07:04 Today William Blair
Procore initiated with an Outperform at William Blair
06:21 Today Canaccord
Procore initiated with a Buy at Canaccord
06:15 Today Oppenheimer
Procore initiated with an Outperform at Oppenheimer
  • 20
    May
PCOR Procore
$83.98 /

-2.47 (-2.86%)

PCOR Procore
$83.98 /

-2.47 (-2.86%)

Hot Stocks
Addus HomeCare announces Robby Stevenson as Chief Human Resource Officer » 08:09
06/14/21
06/14
08:09
06/14/21
08:09
ADUS

Addus HomeCare

$90.89 /

-1.33 (-1.44%)

Addus HomeCare announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

Hot Stocks
Aligos Therapeutics: CAM candidate, STOPS candidate complete Phase 1a studies » 08:08
06/14/21
06/14
08:08
06/14/21
08:08
AGLS

Aligos Therapeutics

$19.38 /

+ (+0.00%)

Aligos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Phunware set to join Russell Microcap Index » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
PHUN

Phunware

$1.40 /

+0.02 (+1.45%)

Phunware is set to join…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PHUN Phunware
$1.40 /

+0.02 (+1.45%)

PHUN Phunware
$1.40 /

+0.02 (+1.45%)

05/11/21 Roth Capital
Phunware initiated with a Buy at Roth Capital
06/16/20 Ascendiant
Ascendiant starts Phunware with Buy rating, $4 price target
06/16/20 Ascendiant
Phunware initiated with a Buy at Ascendiant
PHUN Phunware
$1.40 /

+0.02 (+1.45%)

  • 12
    Feb
Hot Stocks
Lipocine: FDA Clears LPCN 1154 IND application for Phase 2 postpartum study » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
LPCN

Lipocine

$1.33 /

+0.065 (+5.16%)

Lipocine announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

12/10/20 Ladenburg
Lipocine upgraded to Buy after tentative Tlando approval at Ladenburg
12/10/20 Ladenburg
Lipocine upgraded to Buy from Neutral at Ladenburg
  • 26
    Jan
LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

Initiation
Original Bark Company initiated with a Buy at Canaccord » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
BARK

Original Bark Company

$11.87 /

-0.5 (-4.04%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

06/10/21
Fly Intel: Top five analyst initiations
06/10/21 Jefferies
Barkbox initiated with a Buy at Jefferies
BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

Hot Stocks
Rapt Therapeutics reports 'positive' results from Phase 1b RPT193 trial » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
RAPT

Rapt Therapeutics

$18.57 /

-0.15 (-0.80%)

RAPT Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

05/17/21 H.C. Wainwright
Rapt Therapeutics price target lowered to $29 from $32 at H.C. Wainwright
04/12/21 Roth Capital
Roth says Rapt Therapeutics' AACR presentations highlight broad potential
03/12/21 H.C. Wainwright
Rapt Therapeutics price target raised to $32 from $30 at H.C. Wainwright
11/17/20 BMO Capital
Rapt Therapeutics price target lowered to $45 from $51 at BMO Capital
RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

Hot Stocks
Twist Bioscience collaborates with Regeneron for genotyping assay production » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
TWST

Twist Bioscience

$114.75 /

+2.95 (+2.64%)

, REGN

Regeneron

$525.71 /

-6.63 (-1.25%)

Twist Bioscience (TWST)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Goldman Sachs
Twist Bioscience initiated with a Neutral at Goldman Sachs
05/11/21 Piper Sandler
Twist Bioscience recent weakness a buying opportunity, says Piper Sandler
04/12/21
Fly Intel: Top five analyst initiations
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

07:32 Today Argus
Regeneron's multiple bullish signals suggest return to growth, says Argus
05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/07/21 Morgan Stanley
Regeneron price target raised to $495 from $477 at Morgan Stanley
05/06/21 Piper Sandler
Regeneron remains top large cap pick, says Piper Sandler
TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

  • 03
    Dec
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.